We report the use of dexmedetomidine infusion in critically ill infants and children at doses of 0.2–0.7 μg/kg/hr for a median duration of 141 hours. The major findings from our study include 1) ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the United States of Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, a medication for ...
Sedation with Precedex can be continued safely for an extended period, so that sedation can be continued uninterrupted before, during and after mechanical ventilation. Clinically significant episodes ...
Please provide your email address to receive an email when new articles are posted on . Altering the combined doses of dexmedetomidine and propofol impacts mortality risk in patients aged 65 years or ...
LAKE FOREST, Ill., March 18, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that the U.S. Food and Drug ...
Introduction: Surgery is the principal treatment option for early colorectal cancer (CRC). Anesthesia plays a crucial role in any surgery as it allows for a painless procedure. Dexmedetomidine is a ...
NEW HAVEN, Conn., Aug. 06, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in ...
OSAKA, Japan, Aug. 22 Hospira Japan Co., Ltd. today announced it has received an approval for the long-term (greater than 24 hour) use of the sedative "Precedex IV(TM)200ug" (generic name: ...
Patients who received dexmedetomidine for greater than or equal to 72 hours numbered 114. After excluding 16 patients (14 had dexmedetomidine paused during the 72 hours, and two patients for whom we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results